APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Research Report 2026

2 January 2026133 pages

Choose your research edition.

Industry ResearchVaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Guangdong Yongshun Biological Pharmaceutical Co Ltd, Tiankang, Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health, Plec Bioengineering Co., Ltd., Jinyu Bio-Technology, Sinopharm and Guangdong Wens Dahuanong Biotechnology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Company

CNADC

Guangdong Yongshun Biological Pharmaceutical Co Ltd

Tiankang

Tianjin Ruipu Biological Technology Co., Ltd.

Qilu Animal Health

Plec Bioengineering Co., Ltd.

Jinyu Bio-Technology

Sinopharm

Guangdong Wens Dahuanong Biotechnology Co., Ltd.

Chengdu Tianbang Biological Products Co., Ltd.

Boehringer-Ingelheim

Zoetis

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type

Live Vaccine

Inactivated Vaccine

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application

Government Tender

Marketing

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue of Manufacturers (2021-2026) Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Type & Application Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CNADC Company Information Table 19. CNADC Business Overview Table 20. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 22. CNADC Recent Developments Table 23. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information Table 24. Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview Table 25. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 27. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments Table 28. Tiankang Company Information Table 29. Tiankang Business Overview Table 30. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 32. Tiankang Recent Developments Table 33. Tianjin Ruipu Biological Technology Co., Ltd. Company Information Table 34. Tianjin Ruipu Biological Technology Co., Ltd. Business Overview Table 35. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 37. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments Table 38. Qilu Animal Health Company Information Table 39. Qilu Animal Health Business Overview Table 40. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 42. Qilu Animal Health Recent Developments Table 43. Plec Bioengineering Co., Ltd. Company Information Table 44. Plec Bioengineering Co., Ltd. Business Overview Table 45. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 47. Plec Bioengineering Co., Ltd. Recent Developments Table 48. Jinyu Bio-Technology Company Information Table 49. Jinyu Bio-Technology Business Overview Table 50. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 52. Jinyu Bio-Technology Recent Developments Table 53. Sinopharm Company Information Table 54. Sinopharm Business Overview Table 55. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 57. Sinopharm Recent Developments Table 58. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information Table 59. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview Table 60. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 62. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments Table 63. Chengdu Tianbang Biological Products Co., Ltd. Company Information Table 64. Chengdu Tianbang Biological Products Co., Ltd. Business Overview Table 65. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 67. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments Table 68. Boehringer-Ingelheim Company Information Table 69. Boehringer-Ingelheim Business Overview Table 70. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 72. Boehringer-Ingelheim Recent Developments Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 77. Zoetis Recent Developments Table 78. Phibro Animal Health Company Information Table 79. Phibro Animal Health Business Overview Table 80. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 82. Phibro Animal Health Recent Developments Table 83. MSD Animal Health Company Information Table 84. MSD Animal Health Business Overview Table 85. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 87. MSD Animal Health Recent Developments Table 88. Komipharm Company Information Table 89. Komipharm Business Overview Table 90. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 92. Komipharm Recent Developments Table 93. Ceva Company Information Table 94. Ceva Business Overview Table 95. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 97. Ceva Recent Developments Table 98. CAVAC Company Information Table 99. CAVAC Business Overview Table 100. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 102. CAVAC Recent Developments Table 103. Bioveta Company Information Table 104. Bioveta Business Overview Table 105. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 107. Bioveta Recent Developments Table 108. Agrovet Company Information Table 109. Agrovet Business Overview Table 110. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 112. Agrovet Recent Developments Table 113. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021-2026) & (K Units) Table 115. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2021-2026) Table 116. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2027-2032) & (K Units) Table 117. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2027-2032) Table 118. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2021-2026) Table 120. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2027-2032) Table 122. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 124. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 125. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 129. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 130. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 139. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 140. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 148. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 149. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2021-2026) Table 150. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2027-2032) Table 151. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2021-2026) Table 154. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2027-2032) Table 155. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2026) & (US$/Unit) Table 156. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2027-2032) & (US$/Unit) Table 157. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 158. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 159. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2021-2026) Table 160. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2027-2032) Table 161. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2021-2026) Table 164. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2027-2032) Table 165. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2026) & (US$/Unit) Table 166. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List Table 170. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List Table 171. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends Table 172. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers Table 173. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Image Figure 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (2021-2032) & (US$ Million) Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2021-2032) & (K Units) Figure 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) & (2021-2032) Figure 9. Live Vaccine Product Image Figure 10. Inactivated Vaccine Product Image Figure 11. Government Tender Product Image Figure 12. Marketing Product Image Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region in 2025 Figure 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region in 2025 Figure 20. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country in 2025 Figure 21. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2032) Figure 22. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2021-2032) Figure 23. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country in 2025 Figure 26. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2032) Figure 27. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2021-2032) Figure 28. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country in 2025 Figure 34. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2021-2032) Figure 36. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country in 2025 Figure 45. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2032) Figure 46. South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2021-2032) Figure 47. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Colombia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country in 2025 Figure 52. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2021-2032) Figure 54. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2021-2032) Figure 58. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2021-2032) Figure 59. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2021-2032) Figure 60. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2021-2032) Figure 61. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2021-2032) Figure 62. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2021-2032) Figure 63. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain Figure 64. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live Vaccine
  • Inactivated Vaccine
Applications
  • Government Tender
  • Marketing
Companies covered
  • CNADC
  • Guangdong Yongshun Biological Pharmaceutical Co Ltd
  • Tiankang
  • Tianjin Ruipu Biological Technology Co., Ltd.
  • Qilu Animal Health
  • Plec Bioengineering Co., Ltd.
  • Jinyu Bio-Technology
  • Sinopharm
  • Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  • Chengdu Tianbang Biological Products Co., Ltd.
  • Boehringer-Ingelheim
  • Zoetis
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (2021-2032)
  4. 2.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2021-2032)
  5. 2.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Average Price (2021-2032)
  6. 2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live Vaccine
  9. 2.3.3 Inactivated Vaccine
  10. 2.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Government Tender
  13. 2.4.3 Marketing
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Type & Application
  8. 3.8 Global Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Established Date
  9. 3.9 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CNADC
  2. 4.1.1 CNADC Company Information
  3. 4.1.2 CNADC Business Overview
  4. 4.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  6. 4.1.5 CNADC Recent Developments
  7. 4.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd
  8. 4.2.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
  9. 4.2.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
  10. 4.2.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  12. 4.2.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments
  13. 4.3 Tiankang
  14. 4.3.1 Tiankang Company Information
  15. 4.3.2 Tiankang Business Overview
  16. 4.3.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  18. 4.3.5 Tiankang Recent Developments
  19. 4.4 Tianjin Ruipu Biological Technology Co., Ltd.
  20. 4.4.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
  21. 4.4.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
  22. 4.4.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  24. 4.4.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments
  25. 4.5 Qilu Animal Health
  26. 4.5.1 Qilu Animal Health Company Information
  27. 4.5.2 Qilu Animal Health Business Overview
  28. 4.5.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  30. 4.5.5 Qilu Animal Health Recent Developments
  31. 4.6 Plec Bioengineering Co., Ltd.
  32. 4.6.1 Plec Bioengineering Co., Ltd. Company Information
  33. 4.6.2 Plec Bioengineering Co., Ltd. Business Overview
  34. 4.6.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  36. 4.6.5 Plec Bioengineering Co., Ltd. Recent Developments
  37. 4.7 Jinyu Bio-Technology
  38. 4.7.1 Jinyu Bio-Technology Company Information
  39. 4.7.2 Jinyu Bio-Technology Business Overview
  40. 4.7.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  42. 4.7.5 Jinyu Bio-Technology Recent Developments
  43. 4.8 Sinopharm
  44. 4.8.1 Sinopharm Company Information
  45. 4.8.2 Sinopharm Business Overview
  46. 4.8.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  48. 4.8.5 Sinopharm Recent Developments
  49. 4.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  50. 4.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
  51. 4.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
  52. 4.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  54. 4.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments
  55. 4.10 Chengdu Tianbang Biological Products Co., Ltd.
  56. 4.10.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
  57. 4.10.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
  58. 4.10.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  60. 4.10.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments
  61. 4.11 Boehringer-Ingelheim
  62. 4.11.1 Boehringer-Ingelheim Company Information
  63. 4.11.2 Boehringer-Ingelheim Business Overview
  64. 4.11.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  66. 4.11.5 Boehringer-Ingelheim Recent Developments
  67. 4.12 Zoetis
  68. 4.12.1 Zoetis Company Information
  69. 4.12.2 Zoetis Business Overview
  70. 4.12.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  72. 4.12.5 Zoetis Recent Developments
  73. 4.13 Phibro Animal Health
  74. 4.13.1 Phibro Animal Health Company Information
  75. 4.13.2 Phibro Animal Health Business Overview
  76. 4.13.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  78. 4.13.5 Phibro Animal Health Recent Developments
  79. 4.14 MSD Animal Health
  80. 4.14.1 MSD Animal Health Company Information
  81. 4.14.2 MSD Animal Health Business Overview
  82. 4.14.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  84. 4.14.5 MSD Animal Health Recent Developments
  85. 4.15 Komipharm
  86. 4.15.1 Komipharm Company Information
  87. 4.15.2 Komipharm Business Overview
  88. 4.15.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  90. 4.15.5 Komipharm Recent Developments
  91. 4.16 Ceva
  92. 4.16.1 Ceva Company Information
  93. 4.16.2 Ceva Business Overview
  94. 4.16.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  96. 4.16.5 Ceva Recent Developments
  97. 4.17 CAVAC
  98. 4.17.1 CAVAC Company Information
  99. 4.17.2 CAVAC Business Overview
  100. 4.17.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  102. 4.17.5 CAVAC Recent Developments
  103. 4.18 Bioveta
  104. 4.18.1 Bioveta Company Information
  105. 4.18.2 Bioveta Business Overview
  106. 4.18.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  108. 4.18.5 Bioveta Recent Developments
  109. 4.19 Agrovet
  110. 4.19.1 Agrovet Company Information
  111. 4.19.2 Agrovet Business Overview
  112. 4.19.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  114. 4.19.5 Agrovet Recent Developments
5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Scenario by Region
  1. 5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2021-2032
  3. 5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2021-2026
  4. 5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2027-2032
  5. 5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2021-2032
  6. 5.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2021-2026
  7. 5.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2027-2032
  8. 5.4 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  9. 5.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2032)
  11. 5.4.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  15. 5.5.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2032)
  17. 5.5.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  35. 5.7.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2032)
  37. 5.7.3 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  2. 6.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  5. 6.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  2. 7.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  5. 7.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain Analysis
  2. 8.1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process
  5. 8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
  8. 8.2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
9 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Analyzing Market Dynamics
  1. 9.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
  2. 9.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers
  3. 9.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges
  4. 9.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst